Urinary stone treatment devices market seen reaching $5.59B by 2030

The urinary stone treatment devices and equipment market is projected to grow from $4.59 billion in 2026 to $5.59 billion by 2030, driven by rising kidney stone cases, more outpatient procedures, and increased investment in urology technology. North America held the largest regional share in 2025, while Western Europe ranked second.

Why it matters: - The market is tied to growing kidney stone rates and broader access to treatment tools that can reduce pain, complications and recovery time. - Healthcare systems are investing more in procedures and devices that support minimally invasive stone removal. - The category also reflects a wider shift toward outpatient care and specialized urology services.

What happened: - The Business Research Company released its Urinary Stone Treatment Devices And Equipment Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report puts the market at $4.39 billion in 2025 and forecasts $4.59 billion in 2026. - The market is projected to reach $5.59 billion by 2030. - The report was published Sept. 2, 2026, in London. - A free sample of the market report is available. - The full market report is also available.

The details: - The market’s expected 2025-2026 growth rate is 4.5%. - The forecast through 2030 implies a 5.1% CAGR. - Past growth was driven by more kidney stone cases, wider use of extracorporeal shock wave lithotripsy, more specialized urology centers, greater use of endoscopic interventions and better surgical instrument reliability. - Future growth is expected to come from more holmium laser use, more outpatient stone removal, more ambulatory surgery centers, a stronger focus on patient safety and procedural efficiency, and higher investment in advanced urology devices. - The report highlights rising use of laser-based lithotripsy systems, minimally invasive stone extraction tools, precision retrieval instruments, imaging-guided procedures and efforts to reduce recovery times. - Urinary stone treatment devices and equipment are used to diagnose, break down and remove stones in the kidneys and urinary tract. - Kidney stones form when substances such as calcium, uric acid and oxalate crystallize in urine and create solid deposits. - Rising healthcare expenditure is a key growth driver because higher spending expands access to treatment technologies and supports long-term care for chronic illness. - In the UK, healthcare spending rose 5.6% from 2022 to 2023, after a 0.9% increase in the prior year, and total healthcare expenditure reached about $317.63 billion (£292 billion) in 2023. - North America held the largest market share in 2025. - Western Europe ranked as the second-largest regional market. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report version includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - The outlook points to a market moving from broad procedural demand toward more precise, less invasive and more workflow-efficient treatment options. - The regional split suggests North America remains the most established commercial base, while other regions may compete on infrastructure buildout and device adoption. - The healthcare-spending link indicates that reimbursement capacity and system investment remain important demand signals for device makers.

What's next: - Device makers are likely to focus on laser systems, imaging-guided tools and instruments that shorten procedure and recovery times. - Growth will likely track how quickly hospitals and ambulatory surgery centers expand access to stone treatment. - The market’s next phase will depend on adoption of advanced urology devices and continued healthcare investment.